Biopolymer-Based Hydrogel Beads with Enhanced Stability and pH/Ion-Responsive Controlled Release through a
Xiangxiang Lv1,2, Yue Huang3, Mengtao Hu1
1College of Food Science, Southwest University, Chongqing 400715, China.
Biomacromolecules
|June 2, 2025
Summary
Transglutaminase cross-linking enhances gelatin/sodium alginate/carboxylated cellulose nanofibril hydrogel beads. This improves properties and enables precise control over the release of active substances like bovine serum albumin.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Drug Delivery Systems
Background:
- Composite biopolymer hydrogel beads are promising for controlled release applications.
- Gelatin (G), sodium alginate (SA), and carboxylated cellulose nanofibrils (cCNF) offer unique properties for hydrogel formulation.
- Optimizing cross-linking is crucial for tailoring hydrogel bead performance.
Purpose of the Study:
- To investigate the impact of transglutaminase (TG) cross-linking time on G-SA-cCNF hydrogel bead properties.
- To evaluate the structural, swelling, and controlled-release behaviors of the hydrogel beads.
- To assess the pH/ion-responsive characteristics and bioactive substance release.
Main Methods:
- Preparation of G-SA-cCNF hydrogel beads using a dual-cross-linking method with TG and calcium chloride (CaCl2).
- Systematic variation of TG cross-linking time.
- Characterization of hydrogel bead structure, swelling, mechanical properties, thermal stability, and controlled release of bovine serum albumin (BSA).
- Evaluation of responses in simulated gastric and intestinal fluids.
Main Results:
- TG cross-linking significantly improved hydrogel bead sphericity, water-holding capacity, texture, mechanical strength, and thermal stability.
- The hydrogel beads demonstrated distinct pH/ion-responsive swelling behavior, shrinking in simulated gastric fluid and expanding in simulated intestinal fluid.
- TG cross-linking created a denser network structure, facilitating controlled release of BSA.
- Precise regulation of release kinetics was achieved by adjusting TG cross-linking time.
Conclusions:
- Transglutaminase cross-linking is an effective strategy to enhance the performance of G-SA-cCNF composite hydrogel beads.
- The developed hydrogel beads exhibit tunable properties and responsive release profiles suitable for bioactive substance delivery.
- This study provides a foundation for designing advanced hydrogel-based delivery systems with tailored release characteristics.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
137
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


